CompletedEUCTR 2014-004393-41

A double-blind, placebo-controlled study of the impact of prophylactic treatment with Galantamine 8mg of cognitive impairment during an electroconvulsive therapy (ECT) in patients with major depre...

This historical record does not confirm current site availability.

Historical research recordBelgiumDepression

The study in practice

Understand this study

What did researchers investigate?

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.

Listed locations: Belgium
Study phase: Phase 3

Study clarity

Study information

Study start dateNot clearly listed

Recruitment status: Completed
Enrollment listed in the registry: Not clearly listed
Sponsor: CUB Hospital Erasme
Sponsor type: Hospital / academic medical center
Study type: Drug
Intervention type: Medication / drug
Study phase: Phase 3
Locations: Belgium
Age range: Not clearly listed
Official registry ID: EUCTR 2014-004393-41
Official title: Show the full official title
A double-blind, placebo-controlled study of the impact of prophylactic treatment with Galantamine 8mg of cognitive impairment during an electroconvulsive therapy (ECT) in patients with major depre...

Looking for a study you can join?

Explore recruiting studies

Get this study by email

Recruitment & locations

Completed

Belgium

Registry details

Historical country statuses

Belgium — Completed

FAQ

Questions about this study

Who is behind this study?

The study sponsor is CUB Hospital Erasme, a hospital or academic medical center.

Want to explore more studies?

Explore studies